Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2008-04-15 Regulatory Filings
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is titled "Pressmeddelande" (Press Release) dated 2008-04-15 and announces a significant business development: Medivir entering into a collaboration agreement with GlaxoSmithKline (GSK) to market certain products in Sweden. This is a strategic announcement concerning business operations, partnerships, and future financial impact, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific capital change document. Since it details a major business transaction (collaboration/partnership) that impacts future revenue and strategy, it most closely aligns with a general corporate announcement. Given the provided definitions, it does not fit perfectly into the highly specific categories (like DIV, DIRS, 10-K, ER). It is a significant corporate event announcement. In the absence of a specific 'Business Development' or 'Partnership Announcement' code, the most appropriate fallback for a non-standard, material corporate announcement that isn't a standard financial report or insider trade is the general Regulatory Filings category (RNS), as it is a public disclosure of material information. However, since the content is about a strategic agreement and future business plans, it is a material corporate event. If we strictly adhere to the provided list, and recognizing this is a press release announcing a major strategic move (not a financial report itself), RNS is the best fit as a general regulatory disclosure/press release.
2008-04-15 Swedish
Annual Report 2007
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Medivir AB for the year 2007. It contains detailed sections including a table of contents, business highlights, management commentary (VD har ordet), project descriptions, personnel data, and references to financial statements (resultaträkningar, balansräkningar, etc.). Given the depth of information, the inclusion of financial data, and the structure typical of a full-year report, it is classified as an Annual Report (10-K). FY 2007
2008-04-07 Swedish
Report Publication Announcement 2008
Report Publication Announcement Classification · 98% confidence The document is extremely short (458 characters) and functions as a brief announcement stating that the results of a Phase III clinical trial for Lipsovir® were presented at a press conference today, and that the presentation is now available on the company's website. This fits the definition of a Report Publication Announcement (RPA), as it announces the availability of presentation materials rather than being the presentation itself. It is not a full financial report (10-K, IR), an earnings release (ER), or a transcript (CT).
2008-03-19 English
Report Publication Announcement 2008
Report Publication Announcement Classification · 99% confidence The document is very short (490 characters) and explicitly states that presentation materials from a press conference regarding Phase III results are now available on the company's website ('Detta presentationsmaterial finns nu tillgängligt på Medivirs hemsida'). This structure—a brief announcement pointing to the main content elsewhere—strongly suggests a Report Publication Announcement (RPA), as per the 'MENU VS MEAL' rule. It is not the full presentation (IP) or the full financial report (ER/IR/10-K), but an announcement about its availability.
2008-03-19 Swedish
Earnings Release 2007
Earnings Release Classification · 98% confidence The document is titled "MEDIVIRS BOKSLUTSKOMMUNIKÉ 1 januari – 31 december 2007" (Medivir's Year-End Report Communication 1 January – 31 December 2007). It contains key financial highlights for the full year (Net sales, Net result after tax, Cash, EPS) and detailed commentary on clinical trial progress (Hepatitis C, Lipsovir, MIV-701) and business developments. This structure—a summary of annual financial performance combined with operational updates—is characteristic of an Earnings Release (ER) or a preliminary Annual Report summary, but since it covers the full fiscal year and includes detailed financial figures, it functions as the primary announcement of annual results. Given the options, 'ER' (Earnings Release) is the most appropriate fit for a year-end financial summary announcement, even though it is comprehensive. It is not the full 10-K, nor is it a transcript (CT) or a general factsheet (FS). It is a formal communication of annual results. Q4 2007
2008-02-13 Swedish
Annual Report 2007
Annual Report Classification · 95% confidence The document is a 'Financial Statement' for the period 1 January – 31 December 2007, issued by Medivir. It contains consolidated net sales, loss after tax, liquid assets, and earnings per share, along with a detailed CEO's statement and operational updates. Since it covers a full fiscal year and provides comprehensive financial results and analysis, it qualifies as an Annual Report (10-K equivalent for this jurisdiction). Q4 2007
2008-02-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.